The Significance of Pleural Elastica Invasion by lung Carcinomas
|
|
- Kristopher Webster
- 5 years ago
- Views:
Transcription
1 The Significance of Pleural Elastica Invasion by lung Carcinomas BRRY GLLGHER, MD, ND STEFN J. URBNSKI, MD Invasion of visceral pleura by primary lung carcinomas is an important parameter in staging. The complex histology of visceral pleura requires special elastic stains for proper evaluation, yet only approximately 10% of peripheral lung carcinomas seen in consultation (S.J.U.) are thus assessed. The objective of this study was to examine the prognostic importance of microscopic visceral pleura invasion by lung carcinomas. Retrospective analysis of 23 cases of peripheral T2, NO, MO carcinomas with mi- From the Department of Pathology, University of Calgary, Calgary, lberta, Canada; and the Tom Baker Cancer Centre, Calgary, lberta, Canada. ccepted for publication September Kqr wow!.s: lung carcinoma. visceral pleura, invasion. ddress correspondence and reprint requests to Stefan J. Urbanski. MD, Department of Histopathology, Foothills Hospital, St NW, Calgary, lberta, Canada by W.B. Saunders Company /90/ $5.00/O croscopic pleural invasion on elastic stains and a matched control group documented a statistically significant (P = ) difference in survival between squamous cell carcinoma subgroups. This study therefore suggests the need for histologic assessment of peripheral lung carcinomas for invasion of internal pleural elastic lamina. HUM PTHOL 21: by W.B. Saun- ders Company. Several studies have reaffirmed the importance of staging in lung cancer in determining prognosis and treatment.lw5 Of particular importance is the selection of patients who may benefit from radiotherapy in addition to surgery. Visceral pleura invasion by lung carcinomas clearly represents an important parameter in staging and is included in the two major staging classifications. Thus, according to both the International Union gainst Cancer6 and the merican Joint Com- FIGURE 1. n adenocarcinoma is seen to invade through pleural internal elastic lamina (arrow). The invasion is not associated with significant inflammation or fibrosis. (Movat s stain, magnification x 390.)
2 PLEURL INVSION BY LUNG CRCINOMS (Gallagher & Urbanski) mittee s:taging, tumor of any size which invades the visceral pleura is classified as T2. system of nomenclature and histologic criteria for visceral pleura invasion a.re also available8 but because of the structure of pleura these are rather complex and are subdivided into P,, P,,, P,, P,, and P,. There is no study that documents the prognostic and therapeutic slgnificance of various histologic subtypes of visceral pleura invasion. This may partly explain why in the consulted lung malignancies (S.J.U.), among approximately 40 cases of lobectomies for peripheral lung carcinomas seen annually, the status of visceral pleura is assessed in only approximately 10%~ of cases. This study attempted to assess the prognostic importance of pleural internal elastic lamina breaching in primarv lung carcinoma. MTERILS ND METHODS Retrospective analysis ( ) of the files of the Calgary, and the Cross Cancel Institute, Edmonton, identified 1,799 cases of pulmonary carcinoma with information available regarding staging. In this group there were 440 stage I carcinomas. Three hundred sixty-four cases were classified as either Tl, NO, Tom Baker Cancer Centre, MO or T2. NO, MO. ll these cases were then tzxamined. The medical charts were reviewed fbr clinical data and to check the clinically assigned stage. The size and location of the tumor were taken from the gross pathology report in the chart. Histologic assessment was then performed, firstly, to confirm histologic grade and type and secondly, to determine if tumor approached but did not penetrate the pleural surface. In such cases the pleural elastic lamina was assessed using three elastic stains: Verhoeff Van Gieson. Movat s. and Victoria Blue. Five distinct layers have been described in pleuraq: ( 1) Mesothelial layer. This consists of a single layer of variably shaped mesothelium; (2) Submesothelial layer (75 pm). This relatively thin layer consists of connective tissues immediately beneath the mesothelial la!er. (3 I External elastic lamina (100 Fm). This contains elastic fibers. (4) Interstitial layer (250 km). This outer half contains abundant lymphatic vessels and giant capillaries ten times larger than alveolar capillaries. The inner half contains abundant fibrous tissue. (5) Internal elastic lamina (250 km). Closest to the pulmonary parenchyma, it consists of relatively thin elastic fibers and may partly belong to the subpleural tissues. Pleural elastic lamina breaching was defined as invasion by tumor cells of internal pleural elastic lamina and such cases were assigned to the pleural elastic lamina group. FIGURE 2. Squamous cell carcinoma (arrows) has invaded through pleural elastic lamina. There is prominent elastic lamina reduplication and fragmentation, resulting in formation of common elastic lamina. (Movat s stain, magnification x 195.)
3 Volume 21, No. 5 (May HUMN PTHOLOGY FIGURE 3. Occasionally the pleura may undergo fibrosis with retraction of common elastic lamina. Such cases are particularly deceptive and pleural invasion may not be suspected unless the slides are stained for elastic fibers. (Verhoeff-Van Gieson stain, magnification x IOO]. The insert illustrates low magnification of a deep wedge-shaped pleural retraction with fibrosis filling in the created defect. mor size, tumor type, date of diagnosis, and tumor differentiation. The presence of invasion of endothelium-lined spaces was assessed in both groups. With the exception of large-cell carcinoma (treated by lobectomy and radiation) all the other cases were treated by lobectomy only. None of the cases with pleural invasion or the control groups had lymph node metastases. We have analyzed a total of 46 cases, 23 with and 23 without internal pleural elastic invasion (Table 1). Of the cases with pleural elastic invasion, 12 were squamous carcinomas (Table 2). The remaining cases were represented by 10 adenocarcinomas and one large-cell carcinoma. The groups were compared for length of survival. Mean survival rate for each histologic type was also calculated. Statistical analysis of the data was performed with the Kaplan-Meier method, followed by Wilcoxon s test. McNemar s test was done in a separate analysis to confirm the statistical significance of the previously obtained data. In some instances the tumor invaded pleural elastic lamina without eliciting any visible secondary changes (eg, fibrosis, inflammatory response, or elastic lamina reduplication, Fig 1). In other cases breaching of internal elastic lamina was associated with prominent elastic reduplication and inflammatory infiltrate (Fig 2). The value of elastic stains was best documented in those cases where pleural invasion was accompanied by thick fibroblastic proliferation (Fig 3). Only in the first of these three morphologic variants could distinct internal elastic lamina be seen. For this study, therefore, we have decided to diagnose pleural invasion when the tumor cells were seen to invade internal elastic lamina (Fig 1) or common elastic lamina (Fig 2). Those cases where entire pleura was permeated by tumor (P2), with carcinoma cells seen on the pleural surface, were not included in this analysis. matched control group was assembled from those cases of peripheral lung carcinoma without elastica breaching. Factors cross-matched included age, sex, treatment, tutble 1. Total Summary Dead TBLE 2. of ll Cases Percent live Censored Breached Nonbreached Totals Summary of Cases With Squamous Cell Carcinoma Total Dead live Percent Censored Nonbreached Breached Totals
4 PLEURL INVSION BY LUNG CRCINOMS (Gallagher & Urbanski) TBLE 3. Breached Squamous Cell Carcinoma Invasion of Tumor Size Follow-up livei Lndothelium Patient No. ge Sex km) Differentiation TX in months Dead Lined Spaces - I 75 M 4 Moderate 1. 8 D + 2 TO M 6 Moderate F -1 Poor L -1 r) M :i Moderate L 1 I) 5 73 M 5 Moderate I. 10 I) M 3 Poor M 3 Moderare 1. x4.4 - x 61 M 2 Moderate I M 4 Poor 1. x3,i 10 riti IV 1.5 Poor \ M 2.x Moderate L ri1 F 2.5 Poor L 29 -.i\hhre\iations: Ts. treatment: L. lobecromy TBLE 4. Nonbreached Squamous Cell Carcinoma Tumor Size Follow-up Patient No. ge Sex (cm) Differentiation TX in months I 7.3 M 3.5 Poor M 5 Well :I -13 F 3.2 Poor L x M :i Well L I5 5 7i M 3.5 Poor L 84 6 fi 1 M 3.5 Poor- L M 3.5 Poor L 78 x 9 7 ) 63 M I.3 3. I Poor Poor L L IO 7 M 2 Poor L 13 II 74 M 2 Moderate L 16 I2 65 F 2 Poor I. 46,4hhre\,iatiolls: 7-x. treatment: L, lobectom\. --- Invasion of.4livel Endothelium Dead Lined Spaces D rz TBLE 5. Breached-denocarcinoma, Large-Cell Carcinoma In\ asion of Tumor Size Follow-up live! Endothelium Pntient No. ge sex km) Differentiation TX in months Dead Lined Spaces 1 7x M 5 Moderate L ti F 4 Poor I :3 F 5.5 Moderate I F 2.3 Moderate L F 3 Moderate i F 2 Moderate L F 2 Moderate L M.5 Poor L !, M 3 Poor L 45 D + IO 5 1 M 2.2 Moderate L 7 D II 63 M 2.5 Large cell LRx ti D + bbreviations: TX. treatment; L. lobectomy; Rx, radiotherapy. 515
5 HUMN PTHOLOGY Volume 21, No. 5 (May 1990) Patient No. ge Sex TBLE 6. Nonbreached-denocarcinoma, One Large-Cell Carcinoma Tumor Size (cm) Differentiation TX Follow-up in months live/ Dead Invasion of Endothelium Lined Spaces 1 74 M 3 Poor LRx 2 D 2 52 F 2.2 Poor L F 5 Moderate L F 1.2 Moderate L 56 : F Poor Moderate L D M 2 Moderate L M 2 Poor L M 2.1 Poor L 10 D M 3.5 Moderate L M 2.3 Large-cell LRx 78 bbreviations: TX. treatment; L, lobectomy; Rx, radiotherapy Of the 364 cases studied, 173 were peripheral. mong these 173 cases, transpleural carcinoma invasion was described in six original pathology reports and these cases have not been reexamined. Subsequently, we have reexamined with elastic and hematoxylin and eosin (H&E) stains the remaining 167 cases. There were 81 cases of peripheral carcinomas with the original histopathology report describing tumor separated from pleural by normal lung parenchyma or inflammation; no pleural invasion has been seen within this group. The pathology reports of the remaining 86 cases described tumor to closely approximate but not penetrate pleura or did not mention the status of pleura at all. mong these 86 cases, two showed transpleural migration and 23 showed pleural elastica invasion without transpleural migration. We have therefore identified among 173 cases of peripheral carcinoma eight cases with transpleural invasion (4.6%), 23 cases with breaching of pleural elastic laminallaminae (13.3%), and 142 cases without pleural invasion (82.1%). In the group with elastic lamina invasion the distinction between internal and external elastic lamina could not be made in I9 out of 23 cases examined. This was due to fusion and duplication of elastic laminae (common elastic lamina formation, Figs 2 and 3) in 18 cases, and in one case because of marked fragmentation and dispersion of laminae by pools of mutin and inflammation. Formation of common elastic lamina was seen not only among cases with pleural invasion but also in approximately 15% of cases with tumor separate from pleura. The great majority of such cases were associated with endogenous pneumonia. The formation of a common elastic lamina was not associated with any specific histologic tumor type. There were 12 cases of squamous cell carcinoma in both breached and nonbreached pleural elastic lamina groups (Tables 3 and 4), and 10 adenocarcinomas with one large-cell carcinoma in both groups 1.0-w o=breched is COV b= NON-BRECHED Om 0. C p oodooo0 cxmwocoooooo o - 0Rn.o.W is 0. Cm. o= BRECHED 5 0. =NON-BRECHED Ooo UY 0 8 KOCCOO J I 0.01,,,,, (,,,,, MOS FIGURE 4. Kaplan-Meier survival analysis of all cases I31 MOS FIGURE 5. Kaplan-Meier survival analysis of cases with squamous cell carcinoma. 516
6 PLEURL INVSION BY LUNG CRCINOMS (Gallagher & Urbanski) (Tables 5 and 6). In both squamous cell carcinoma groups there were 10 males and two females. In the breached adenocarcinoma-large cell group there were six females and five males whereas in the nonbreached group there were five females and six males. t the time of analysis, 15 in the breached group and 19 in the control group were still alive. Eight of 11 patients were still alive in both adenocarc-inoma and large cell carcinoma groups. In the squamous cell carcinoma groups seven of 12 in the breached group and 11 of 12 in the nonbreached group wlere still alive. Kaplan-Meier survival analysis data are shown in Figs 3 and 5. generalized Wilcoxon test showed no significant differ.ence between the overall breached and nonlbreached groups. However, there was a significant diff-erence (P = ) between the squamous cell carcinoma breached and nonbreached groups. This was confirmed on McNemar s test. DISCUSSION ccurate staging is important in determining prognosi:s and treatment for lung carcinoma. Indeed. one study showed that tumor stage was the only significant predictor of survival.2 Furthermore, the assessment of treatment protocols requires that cases be accurately staged. This study found that invasion of the internal pleural elastic lamina significantly reduced the survival rate of patients with peripheral squamous cell carcinoma. It has recently been asserted that peripheral squamous cell carcinoma may carry a better prognosis than central squamous cell carcinoma. Our findings may not be at variance with this; rather, we have delineated a small subgroup of these tumors with a worse prognosis. It is not known why the squamous cell carcinomas with ibreached pleural elastic lamina have a worse prognosis. Intrathoracic spread may be enhanced as occurred with at least one patient in the breached pleural elastic lamina group. lternatively, it may be that the ability of the tumor to breach the pleural elastic lamina is a measure of its invasive potential. In our material the tumors with pleural invasion were on average slightly larger (mean values 3.6/3.2 for squamous, for adenocarcinoma). The significance of this difference is uncertain. Survival rate of the squamous cell carcinoma group wi1.h pleural invasion resembles the stage II tumors more than stage I and therefore radiotherapy may be appropriate for these patients in addition to surgical therapy. Existing histologic criteria for pleural involvement by lung carcinomas recognize five separate variants. There is no uniformity in interpretation of this histologic finding, however, and a significant proportion of lung cancer resections are not assessed by elastic stain. lthough the visceral pleura has obviously been permeated when tumor cells are present on its surface (P2) or the pleural effusions contain tumor cells, a problem of interpretation arises when tumor breaches the pleural elastic larnina but is not present on the pleural surface. The histologic criteria for pleural invasion used initially in our study closely match the P, category in which visceral pleural elastica is invaded. It was subsequently found that in the great majority of cases with pleural invasion the distinction between pleural elastic laminae cannot usually be made, as a common elastic lamina is formed (Figs 2 and 3). It is suggested on the basis of these findings that invasion of either internal elastic lamina or common elastic lamina should be considered indicative of pleural invasion. Occasionally, reactive fibrosis may occur on the pleural surface overlying an area of in\,asion (Fig 3). The tumor in such cases will appear on H&E to be several millimeters away from the pleura, while, in fact, the pleura may be extensively invaded by carcinoma. Pleural invasion in most instances may be visualized only by application of elast.ic stains. The performance of elastic stains is simple and inexpensive but the interpretation of the histologic results may create some difficulty. In summary, the findings of this study confirm the need for histologic assessment of peripheral pulmonary carcinomas for invasion of pleural elastic lamina. If present, such a finding should be considered indicative of pleural invasion and staged appropriately. REFERENCES 1. Elson CE. Roggli VL, Vollmer RT, et al: Prognostic indicators for survival in Stage I carcinoma of the lung: histologic stud, ot 37 surgically resected cases. Mod Pathol l:ii(x-291, Greenbern SD. Fraire E. Kinner BM. 151 al: Tumor cell type versus sta&g in the prognosis of carcinoma of the lung. Path01 nnu 22: , Naruke T, Suemasu K. Ishikawa S: Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76: Shields TW. Humphrey EW. Matthews M. Eastridge CE. Keehn RJ: Pathologic stag; grouping of patients with resected carcinoma of the lung. I Thorac a Cardiovasc Surer 80: I 0 5. Roggli VL, Vollmer RT. Greenberg SD. et al: Lung cancer heterogeneity: blinded and randomized studv of 100 consecutive cases. I?u.M ti~1.m. 16: Hermaneck P. Sobin LH: TNM Classificaticm 01 Malirmant Tumors (ed 4). New York, NY, Springer-Verlag, p 70y 7. Mountain CF: new international staging system for lung cancer. Chest 89: , 1986 (Suppl) 8. Dail DH, Hammar SP (eds): Pulmonarv Pathology. Nen York. NY. Springer-Verlag. 1988, p Nagaishi C: Functional natomy and H~stologv of the Lung. Baltimore, MD, University Park, Tomashefski JF, Rosenthal E, Connors F: Peripheral vs central squamous cell carcinomas of the lung. comparison of clinical features. histopathology and survival. Mod Path01 1:
Visceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationInvasion to the visceral pleura is an important component
Diagnosis of Visceral Pleural Invasion by Lung Cancer Using Intraoperative Touch Cytology Yushi Saito, MD, PhD, Yosuke Yamakawa, MD, PhD, Masanobu Kiriyama, MD, PhD, Ichiro Fukai, MD, PhD, Satoshi Kondo,
More informationPrognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer
Jpn. J. Clin. Oncol. 198, 1 (), 7-1 Prognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer KEIICHI SUEMASU, M.D. AND TSUGUO NARUKE, M.D. Department of Surgery,
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationIn the mid 1970s, visceral pleural invasion (VPI) was included
ORIGINAL ARTICLE Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients Hajime Otsuka, MD,* Genichiro Ishii, MD, PhD,*
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationCollaborative Stage. Site-Specific Instructions - LUNG
Slide 1 Collaborative Stage Site-Specific Instructions - LUNG In this presentation, we are going to review the AJCC Cancer Staging criteria for the lung primary site. Slide 2 Reading Assignments As each
More informationThe prognostic significance of central fibrosis of adenocarcinoma
Prognostic Significance of the Size of Central Fibrosis in Peripheral Adenocarcinoma of the Lung Kenji Suzuki, MD, Tomoyuki Yokose, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Kenro Takahashi, MD, Kanji
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationThe tumor-node-metastasis (TNM) system is
LUNG CARCINOMA STAGING PROBLEMS Philip T. Cagle, MD a,b, * KEYWORDS Lung Carcinoma Staging Tumor-node-metastasis TNM system ABSTRACT The tumor-node-metastasis (TNM) system is the most commonly used staging
More informationVisceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size
GENERAL THORACIC Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD, Neda Kalhor, MD, Wayne L. Hofstetter,
More informationPrognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution
Maruyama et al General Thoracic Surgery Prognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution Riichiroh Maruyama, MD Fumihiro
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationA916: rectum: adenocarcinoma
General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationNew lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma
July 2016 New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma Contributed by: Laurel Rose, MD, Resident Physician, Indiana University School of Medicine,
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationVisceral pleural invasion (VPI) of lung cancer has been
ORIGINAL ARTICLE Visceral Pleural Invasion Classification in Non Small- Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer: Validation Analysis Based on a
More informationTHE PROGNOSTIC SIGNIFICANCE OF TUMOR CELL DETECTION IN INTRAOPERATIVE PLEURAL LAVAGE AND LUNG TISSUE CULTURES FOR PATIENTS WITH LUNG CANCER
THE PROGNOSTIC SIGNIFICANCE OF TUMOR CELL DETECTION IN INTRAOPERATIVE PLEURAL LAVAGE AND LUNG TISSUE CULTURES FOR PATIENTS WITH LUNG CANCER J. Buhr, MD a K. H. Berghfiuser, MD b S. Gonner, MD b C. Kelm,
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationMediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma*
Mediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma* Mediastinal Nodal Metastases in Lung Cancer Yoh Watanabe, M.D., F.C.C.P.; ]unzo Shimizu, M.D.; Makoto Tsubota, M.D.; and Takashi
More informationCase Report. A Surgical Case of Venous Aneurysm of the Cephalic Vein. with Unique Clinicopathological Findings for Venous Dissection
Case Report A Surgical Case of Venous Aneurysm of the Cephalic Vein with Unique Clinicopathological Findings for Venous Dissection Takashi Kobata, 1 Sohsuke Yamada, 2,3* Ken-ichi Mizutani, 2 Nozomu Kurose,
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationP sumed to have early lung disease with a favorable
Survival After Resection of Stage I1 Non-Small Cell Lung Cancer Nael Martini, MD, Michael E. Burt, MD, PhD, Manjit S. Bains, MD, Patricia M. McCormack, MD, Valerie W. Rusch, MD, and Robert J. Ginsberg,
More informationIntraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer
Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Yasushi Shintani, MD, hd, a Mitsunori Ohta, MD, hd, a Teruo Iwasaki, MD, hd, a Naoki
More informationLung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.
Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationSite of Recurrence in Patients. of the Lung Resected for Cure. with Stages I and I1 Carcinoma
Site of Recurrence in Patients with Stages I and I1 Carcinoma of the Lung Resected for Cure Steven C. Immerman, M.D., Robert M. Vanecko, M.D., Willard A. Fry, M.D., Louis R. Head, M.D., and Thomas W. Shields,
More informationLA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II
AUSL BA/4 Ospedale S. Paolo Bari U.O. Complessa di Chirurgia Toracica LA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II stadio L opinione del chirurgo Francesco
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationTumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma
Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given
More informationLarge blocks in prostate and bladder pathology
Large blocks in prostate and bladder pathology Farkas Sükösd Department of Pathology, University of Szeged The history of the large block technique in radical prostatectomy and cystectomy The first large
More informationMediastinal Staging. Samer Kanaan, M.D.
Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationSupplemental Information
Supplemental Information Prediction of Prostate Cancer Recurrence using Quantitative Phase Imaging Shamira Sridharan 1, Virgilia Macias 2, Krishnarao Tangella 3, André Kajdacsy-Balla 2 and Gabriel Popescu
More informationDisorders of Cell Growth & Neoplasia. Histopathology Lab
Disorders of Cell Growth & Neoplasia Histopathology Lab Paul Hanna April 2010 Case #84 Clinical History: 5 yr-old, West Highland White terrier. skin mass from axillary region. has been present for the
More informationStaging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates
Staging Challenges in Lower GI Cancers Sanjay Kakar, MD University of California, San Francisco March 05, 2017 Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationPrognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer
CHEST Original Research Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer Jung-Jyh Hung, MD, PhD ; Wen-Juei Jeng, MD ; Wen-Hu
More information8th Edition of the TNM Classification for Lung Cancer. Proposed by the IASLC
8th Edition of the TNM Classification for Lung Cancer Proposed by the IASLC Introduction Stage classification - provides consistency in nomenclature - improves understanding of anatomic extent of tumour
More informationWell-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report
Showa Univ J Med Sci 25 1, 67 72, March 2013 Case Report Well-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report Yuri TOMITA
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More information290 Clin Oncol Cancer Res (2009) 6: DOI /s
290 Clin Oncol Cancer Res (2009) 6: 290-295 DOI 10.1007/s11805-009-0290-9 Analysis of Prognostic Factors of Esophageal and Gastric Cardiac Carcinoma Patients after Radical Surgery Using Cox Proportional
More informationTumour size as a prognostic factor after resection of lung carcinoma
Tumour size as a prognostic factor after resection of lung carcinoma A. S. SOORAE AND R. ABBEY SMITH Thorax, 1977, 32, 19-25 From the Cardio-Thoracic Unit, Walsgrave Hospital, Clifford Bridge Road, Coventry
More informationSurgery remains the mainstay treatment for localized
Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome? Yasuhiko Ohta, MD, Ryuichi Waseda, MD, Hiroshi Minato, MD, Naoki Endo,
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationBronchial Carcinoma and the Lymphatic Sump: The Importance of Bronchoscopic Findings
Bronchial Carcinoma and the Lymphatic Sump: The Importance of Bronchoscopic Findings Gordon F. Murray, M.D., Ormond C. Mendes, M.D., and Benson R. Wilcox, M.D. ABSTRACT The lymphatic sump of Borrie is
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationPrognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer
Prognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer Jagan Rao, FRCS(C-Th), Rana A. Sayeed, FRCS(C-Th), Sandra Tomaszek, Stefan Fischer, MD, Shaf Keshavjee, MD, FRCSC, and Gail
More informationDisclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose
Tumor Budding in Colorectal Carcinoma: What, Why, and How Disclosures I have nothing to disclose Soo-Jin Cho, MD, PhD Assistant Professor UCSF Dept of Pathology Current Issues in Anatomic Pathology 2017
More informationNeoplasia literally means "new growth.
NEOPLASIA Neoplasia literally means "new growth. A neoplasm, defined as "an abnormal mass of tissue the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the
More informationThoracic Surgery; An Overview
Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease
More informationShort- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer
Original Article Short- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer Takeshi Kawaguchi, MD, Takashi Tojo, MD, Keiji Kushibe, MD, Michitaka Kimura, MD, Yoko Nagata, MD, and Shigeki
More informationACOSOG Thoracic Committee. Kemp H. Kernstine, MD PhD
ACOSOG Thoracic Committee Kemp H. Kernstine, MD PhD ACOSOG Thoracic Committee Chair: Bryan Meyers, M.D., MPH Vice Chairs: Malcolm Brock, MD Tom DiPetrillo, M.D. Ramaswamy Govindan, M.D. Carolyn Reed, MD
More informationClinico-pathological Evaluation of Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma Keywords :
29 2 14 4 Clinico-pathological Evaluation of Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma Yasuhiko Tsuyama, Takashi Nakatsuka, Yoshiyuki Mori, Tsuyoshi Takato (Department of Plastic
More informationWedge Biopsy for Diffuse Lung Diseases
Chapter VI Wedge Biopsy for Diffuse Lung Diseases Wedge biopsy via thoracoscopic biopsy or open lung biopsy is occasionally performed to obtain tissue for the diagnosis of a diffuse lung disease. A wedge
More informationControversies in Breast Pathology ELENA PROVENZANO ADDENBROOKES HOSPITAL, CAMBRIDGE
Controversies in Breast Pathology ELENA PROVENZANO ADDENBROOKES HOSPITAL, CAMBRIDGE Neoadjuvant Chemotherapy Indications: Management of locally advanced invasive breast cancers including inflammatory breast
More informationLUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS
LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION
More informationLung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09
Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung
More informationThe International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements
Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.
More informationNeoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
More information5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.
Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a
More informationPulmonary resection remains the most effective. Survival in Synchronous vs Single Lung Cancer. Upstaging Better Reflects Prognosis
Survival in Synchronous vs Single Lung Cancer Upstaging Better Reflects Prognosis Marcel Th. M. van Rens, MD; Pieter Zanen, MD, PhD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD;
More informationIn non small cell lung cancer, metastasis to lymph nodes, the N factor, is
Okada et al General Thoracic Surgery Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors Morihito Okada, MD, PhD Toshihiko Sakamoto, MD,
More informationHistopathology: Vascular pathology
Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these
More informationEFFECTIVENESS OF TALC SLURRY IN PRODUCING PLEURODESIS: A STUDY IN RABBITS
Trakia Journal of Sciences, Vol. 5, No. 3-4, pp 7-11, 2007 Copyright 2007 Trakia University Available online at: http://www.uni-sz.bg ISSN 1312-1723 Original Contribution EFFECTIVENESS OF TALC SLURRY IN
More informationAggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure
ISPUB.COM The Internet Journal of Pathology Volume 19 Number 1 Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure A Julai, G Wathuge Citation A Julai, G Wathuge. Aggressive
More informationNEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.
NEOPLASIA-I CANCER Nam Deuk Kim, Ph.D. 1 2 Tumor in the hieroglyphics of the Edwin Smith papyrus (1,600 B.C., Breasted s translation 1930) 3 War on Cancer (National Cancer Act, 1971) 4 Cancer Acts in Korea
More informationCT Findings of Surgically Resected Pleomorphic Carcinoma of the Lung in 30 Patients
Kim et al. CT of Pleomorphic Carcinoma of the Lung Chest Imaging Clinical Observations Tae Sung Kim 1 Joungho Han 2 Kyung Soo Lee 1 Yeon Joo Jeong 1 Seo Hyun Kwak 1 Hong Sik Byun 1 Myung Jin Chung 1 Hojoong
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies
More informationBronchogenic Carcinoma
A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most
More informationClinical Usefulness of the WHO Histological Classification of Thymoma
Original Article Clinical Usefulness of the WHO Histological Classification of Thymoma Satoshi Sonobe, MD, 1 Hideaki Miyamoto, MD, 1 Hiroshi Izumi, MD, 2 Bunsei Nobukawa, MD, 2 Toshiro Futagawa, MD, 1
More informationBone Metastases in Muscle-Invasive Bladder Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer
More informationThe cardiovascular system
The cardiovascular system Components of the Cardiovascular system Heart Vessels: Arteries Capillaries Veins Functions of CVS: Transportation system where blood is the transporting vehicle Carries oxygen,
More informationVATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS
VATS Metastasectomy Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute Disclosures Speaking & Education:
More information3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Lung Cancer T STAGE OUTLINE SURVIVAL ACCORDING TO SIZE ONLY
Pathologic Staging Updates in Lung Cancer Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME
More informationcame from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationMuco-epidermoid tumours of the anal canal
J. clin. Path. (1963), 16, 200 Muco-epidermoid tumours of the anal canal B. C. MORSON AND H. VOLKSTADT From the Research Department, St. Mark's Hospital, London SYNOPSIS The pathology of 21 cases of muco-epidermoid
More informationClinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer
Original Article Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer Jun Zhao*, Jiagen Li*, Ning Li, Shugeng Gao Department of Thoracic Surgery, National
More informationPleomorphic carcinoma of the lung: which CT findings predict poor prognosis?
Pleomorphic carcinoma of the lung: which CT findings predict poor prognosis? Poster No.: C-1887 Congress: ECR 2015 Type: Scientific Exhibit Authors: A. Fujisaki, T. Aoki, S. Kinoshita, Y. Hayashida, Y.
More informationEXPERIMENTAL PLEURAL EMPYEMA PATHOLOGIC CHANGES
Trakia Journal of Sciences, Vol. 3, No. 2, pp 61-65, 2005 Copyright 2005 Trakia University Available online at: http://www.uni-sz.bg ISSN 1312-1723 Original Contribution EXPERIMENTAL PLEURAL EMPYEMA PATHOLOGIC
More informationTNM classifications have been established for various
Lymphogenous and Hematogenous Metastasis of Thymic Epithelial Tumors Kazuya Kondo, MD, PhD, and Yasumasa Monden, MD, PhD Department of Oncological and Regenerative Surgery, School of Medicine, University
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationThe tumor, node, metastasis (TNM) staging system of lung
ORIGINAL ARTICLE Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease Hao-Xian Yang, MD, PhD,* Xue Hou, MD, Peng Lin,
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationPulmonary Metastasectomy for Pulmonary Metastases of Head and Neck Squamous Cell Carcinomas
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationHistopathologic Prognostic Factors in Resected Colorectal Lung Metastases
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Yukinori Murata, MT, Koji Tsuta,
More information